Notes
including either brand, formulation, or dose-specific issues; were related to mortality; were related only to a subgroup of patients; or were related to drug interactions.
Reference
Donegan K, et al. Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study. Drug Safety : [12 pages], 3 May 2018. Available from: URL: https://doi.org/10.1007/s40264-018-0675-x
Rights and permissions
About this article
Cite this article
Electronic healthcare records useful for early signals in UK. Reactions Weekly 1702, 7 (2018). https://doi.org/10.1007/s40278-018-46117-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-46117-8